|
⚲
|
| Keyboard |
| Slaoui Moncef
✚
|
|
|---|---|
| CIK # | 0001712369 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001712369] | |
| 4 | [0001712369] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vaxcyte Inc | |
| Slaoui Moncef | |
| Arcturus Therapeutics Holdings Inc | |
| Moderna Inc | |
| Intellia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arcturus Therapeutics Holdings Inc ARCT
Stock option (right to buy) · derivative
|
2025-06-09 | Grant | 15,000 | $0.00 | |
|
Arcturus Therapeutics Holdings Inc ARCT
Stock option (right to buy) · derivative
|
2024-06-19 | Grant | 14,794 | $0.00 | |
|
Arcturus Therapeutics Holdings Inc ARCT
Stock option (right to buy) · derivative
|
2024-06-19 | Grant | 15,000 | $0.00 | |
|
Moderna Inc MRNA
Stock Option (Right to Buy) · derivative
|
2020-04-29 | Grant | 18,270 | $0.00 | |
|
Moderna Inc MRNA
Stock Option (Right to Buy) · derivative
|
2019-06-27 | Grant | 54,660 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2017-07-25 | Grant | 38,000 | $0.00 |